Company Tagline
EPICS is a drug discovery and development company for small molecule drugs targeting RNA epigenetic mecanisms of cancer
Industry Category
Business Keywords
Company Description
EPICS Therapeutics is a dynamic biotechnology research company dedicated to the discovery and development of innovative small molecule drugs. Focusing on RNA epigenetic mechanisms, EPICS Therapeutics is at the forefront of developing novel clinical agents designed to address critical unmet medical needs in oncology.
Located at 47 Adrienne Bolland, Gosselies, Wallonie 6041, BE, EPICS Therapeutics is committed to meeting high value-added endpoints through rigorous research and development. The company balances risk and reward in its approach to partnering programs, ensuring strategic growth and impactful outcomes in the fight against cancer.
EPICS Therapeutics is rapidly advancing in the biotechnology sector, and more information about their cutting-edge work will be available soon, with the support of the company’s management. We invite the manager of EPICS Therapeutics to create a customized and exclusive company showcase and product listing on our platform to further highlight their contributions to biotechnology research and drug development.
Key Personnel / Employees
Similar Companies
Other organizations in the same industry
INNOAQUA Project
Biotechnology-ResearchSustainable Aquaculture Practices for Innovative Algae-based foods.
BioConnect Innovation Centre
Biotechnology-ResearchBioConnect helps members and partners use the power of biotechnology to innovate to make new sustain...
CL Biologics
Biotechnology-ResearchEnabling High Quality, Affordable Biologics Worldwide
Clinibase
Biotechnology-ResearchFull-service clinical trial recruitment. Real-time data. Outcome-based pricing. CTMS + eSource.
Alternative Company Names
This company is also known as